logo
Select company
Select metric
$ 116.58MWorking Capital
VS
Market
56
Sector
56
Industry
57
History
28
$ 1.65Close
$ 0.67 - $ 1.82 52-Week Range
Ticker Information

Ticker

CHRS

Company Name

COHERUS ONCOLOGY INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

COHERUS ONCOLOGY INC - Working Capital Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

CHRS - Working Capital Historical data
DateCurrent AssetsCurrent LiabilitiesWorking Capital
6/30/2025$ 380.2M$ 263.63M$ 116.58M
3/31/2025$ 310.18M$ 255.04M$ 55.13M
12/31/2024$ 341.58M$ 282.98M$ 58.6M
9/30/2024$ 369.02M$ 295.57M$ 73.46M
6/30/2024$ 557.93M$ 463M$ 94.93M
3/31/2024$ 627.48M$ 538.3M$ 89.17M
12/31/2023$ 475.63M$ 331.77M$ 143.86M
9/30/2023$ 444.37M$ 239.66M$ 204.71M
6/30/2023$ 385.48M$ 169.44M$ 216.04M
3/31/2023$ 315.93M$ 123.41M$ 192.52M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • COHERUS ONCOLOGY INC's latest trailing twelve months (TTM) Working Capital stands at $ 593.49M.
  • Over the past 5 years, COHERUS ONCOLOGY INC's average Working Capital has been $ 258.34M.
  • The median Working Capital for COHERUS ONCOLOGY INC during this period was $ 229.29M
  • COHERUS ONCOLOGY INC reached its highest Working Capital over the past 5 years at $ 621.83M.
  • The lowest Working Capital recorded by COHERUS ONCOLOGY INC in the same timeframe $ 55.13M

COHERUS ONCOLOGY INC's Working Capital vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Working Capital Benchmarks
CompanyWorking Capital
MGNX : MACROGENICS INC $ 165.94MIGMS : IGM BIOSCIENCES INC $ 100.93MSTRO : SUTRO BIOPHARMA INC $ 157.38MAGEN : AGENUS INC $ -221.22MATRA : ATARA BIOTHERAPEUTICS INC $ 10.21MCELU : CELULARITY INC $ -51.96MCSBR : CHAMPIONS ONCOLOGY INC $ -1.68MKPTI : KARYOPHARM THERAPEUTICS INC $ -1.35MIPSC : CENTURY THERAPEUTICS INC $ 145.22MIVVD : INVIVYD INC $ 14.83M

Definition of Working Capital

[Calculation] The working capital represents the capital used in day-to-day operations. It is the difference between a company’s short-term assets [AssetsC] and current liabilities [LiabilitiesC].
AssetsC - LiabilitesC
(=) Working Capital
Working Capital for COHERUS ONCOLOGY INC is calculated as follows: AssetsC [ $ 726.92M ] - LiabilitesC [ $ 133.43M ]
(=) Working Capital [ $ 593.49M ]

CHRS - Working Capital, Last 5 years

$ 55.13M

Minimum

Mar 31, 2025

$ 621.83M

Maximum

Dec 31, 2020

$ 258.34M

Average

$ 229.29M

Median

Working Capital Benchmark Analysis

The chart above depicts the distribution of Working Capital for companies in the Total Stock Market. The average Working Capital of the companies is $ 96.42M with a standard deviation of $ 173.65M.
The following table provides additional summary stats:
Working Capital in the Market:
filtered constituents2.79K
min$ -457.39M
max$ 607.04M
average$ 96.42M
median$ 32.11M
std$ 173.65M